BTLS — Biotalys NV Cashflow Statement
0.000.00%
Last trade - 00:00
- €96.47m
- €78.87m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -9.24 | -13.3 | -18.1 | -22.5 | -20.9 |
Depreciation | |||||
Non-Cash Items | -0.116 | 0.139 | 0.093 | 0.91 | 0.557 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.541 | 2.57 | -0.238 | -0.045 | 0.265 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -8.22 | -9.53 | -16.8 | -20.1 | -18.3 |
Capital Expenditures | -0.645 | -3.93 | -1.33 | -0.707 | -0.455 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.004 | -2.08 | 0.008 | 0.023 | 0.688 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.641 | -6.02 | -1.32 | -0.684 | 0.233 |
Financing Cash Flow Items | -0.023 | -0.039 | -0.245 | -0.245 | -0.158 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 24.5 | 15.3 | 51.1 | -1.24 | 5.53 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 15.6 | -0.255 | 33 | -22 | -12.5 |